Rating Context and Current Position
On 13 November 2025, MarketsMOJO revised the rating of Natural Capsules Ltd from 'Sell' to 'Strong Sell', reflecting a significant deterioration in the company’s overall outlook. The Mojo Score plummeted by 41 points, dropping from 44 to a mere 3, signalling heightened concerns about the stock’s prospects. This rating serves as a cautionary signal for investors, indicating that the stock currently exhibits substantial risks and challenges that outweigh potential rewards.
It is important to note that while the rating change occurred in November 2025, all financial data, returns, and fundamental indicators referenced below are current as of 28 January 2026. This ensures that investors receive an up-to-date assessment of the company’s health and market performance.
Quality Assessment: Below Average Fundamentals
As of 28 January 2026, Natural Capsules Ltd’s quality grade remains below average, reflecting persistent operational and profitability issues. The company continues to report operating losses, undermining its long-term fundamental strength. The average Return on Equity (ROE) stands at a modest 8.15%, indicating limited profitability relative to shareholders’ funds. This level of ROE is insufficient to inspire confidence in the company’s ability to generate sustainable returns for investors.
Moreover, recent quarterly results have been disappointing. The company posted a net loss (PAT) of ₹6.99 crores in the latest quarter, representing a sharp decline of 402.9% compared to the previous four-quarter average. Interest expenses have also surged, with the latest six-month figure rising by 63.84% to ₹5.21 crores, further pressuring the company’s earnings and cash flow.
Valuation: Risky and Unfavourable
Currently, the stock is classified as risky from a valuation standpoint. It trades at levels that are unfavourable compared to its historical averages, reflecting investor concerns about the company’s deteriorating financial health. Over the past year, Natural Capsules Ltd has delivered a negative return of 42.03%, underscoring the market’s lack of confidence.
The company’s profits have plunged dramatically, with a staggering 650.2% decline over the last year. This sharp contraction in profitability, combined with negative operating margins, contributes to the stock’s risky valuation profile. Investors should be wary of the elevated downside risks given these valuation metrics.
Financial Trend: Negative Momentum
The financial trend for Natural Capsules Ltd remains firmly negative as of 28 January 2026. The company’s Return on Capital Employed (ROCE) for the half-year period is at a low of -1.11%, signalling inefficient use of capital and ongoing losses. This negative ROCE highlights the challenges the company faces in generating returns above its cost of capital.
Additionally, the stock’s price performance has been weak across multiple time frames. It has declined by 2.19% in the last trading day, 9.77% over the past month, and 25.08% in the last three months. The year-to-date return is also negative at -3.85%, reinforcing the downward momentum. Over the last six months, the stock has lost 23.90% of its value, reflecting sustained investor pessimism.
Technicals: Bearish Outlook
From a technical perspective, the stock is rated bearish. The consistent underperformance against the benchmark BSE500 index over the past three years further emphasises the weak technical setup. Natural Capsules Ltd has underperformed the broader market in each of the last three annual periods, signalling a lack of positive price catalysts and investor interest.
The bearish technical grade suggests that the stock is likely to face continued selling pressure unless there is a significant turnaround in fundamentals or market sentiment. Investors should approach the stock with caution, considering the prevailing negative technical signals.
Implications for Investors
The 'Strong Sell' rating from MarketsMOJO indicates that Natural Capsules Ltd currently presents considerable risks for investors. The combination of below-average quality, risky valuation, negative financial trends, and bearish technicals suggests that the stock is not well positioned for near-term recovery or growth. Investors seeking capital preservation or growth opportunities may find better prospects elsewhere in the Pharmaceuticals & Biotechnology sector or broader market.
For those holding the stock, this rating serves as a prompt to reassess their exposure and consider risk mitigation strategies. New investors are advised to exercise caution and conduct thorough due diligence before considering any position in Natural Capsules Ltd.
Our latest monthly pick, this Large Cap from Aluminium & Aluminium Products, is outperforming the market! See the analysis that helped our Investment Committee select this winner.
- - Market-beating performance
- - Committee-backed winner
- - Aluminium & Aluminium Products standout
Summary
In summary, Natural Capsules Ltd’s current 'Strong Sell' rating reflects a comprehensive assessment of its financial and market position as of 28 January 2026. The company faces significant headwinds including operating losses, deteriorating profitability, risky valuation, and a bearish technical outlook. These factors collectively justify the cautious stance recommended by MarketsMOJO.
Investors should carefully weigh these considerations in their portfolio decisions and monitor any future developments that could alter the company’s outlook.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
